Edward Samuel BSc, MSc, PhD

Ed has more than 15 years of industry and academic experience in process development, technology transfer, GMP manufacturing and regulatory affairs in the field of cell and gene therapy. Before joining Achilles, Ed was the EU Cell Therapy Operations Manager at Orchard Therapeutics where he was responsible for establishing the functional infrastructure to enable cell therapy manufacturing in the EU and to support regulatory submissions in the US and Europe. Prior to this, Ed held positions at Cognate BioServices Ltd as Director for Manufacturing and in post-doctoral translational research at University College London (UCL). He holds a PhD in T cell immunology and transplantation from UCL, and an MSc in Medical Immunology from King’s College London.